- Home
- MBI vs TNGX Comparison
MBI vs TNGX Comparison
Compare MBI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- TNGX
- Stock Information
- Founded
- MBI 1973
- TNGX 2014
- Country
- MBI United States
- TNGX United States
- Employees
- MBI N/A
- TNGX N/A
- Industry
- MBI Property-Casualty Insurers
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- TNGX Health Care
- Exchange
- MBI Nasdaq
- TNGX Nasdaq
- Market Cap
- MBI 219.6M
- TNGX 351.2M
- IPO Year
- MBI 1987
- TNGX N/A
- Fundamental
- Price
- MBI $4.42
- TNGX $5.87
- Analyst Decision
- MBI Buy
- TNGX Strong Buy
- Analyst Count
- MBI 2
- TNGX 6
- Target Price
- MBI $6.25
- TNGX $12.20
- AVG Volume (30 Days)
- MBI 178.8K
- TNGX 2.9M
- Earning Date
- MBI 08-05-2025
- TNGX 08-06-2025
- Dividend Yield
- MBI N/A
- TNGX N/A
- EPS Growth
- MBI N/A
- TNGX N/A
- EPS
- MBI N/A
- TNGX N/A
- Revenue
- MBI $37,000,000.00
- TNGX $40,990,000.00
- Revenue This Year
- MBI N/A
- TNGX N/A
- Revenue Next Year
- MBI N/A
- TNGX N/A
- P/E Ratio
- MBI N/A
- TNGX N/A
- Revenue Growth
- MBI 285.71
- TNGX 10.09
- 52 Week Low
- MBI $3.22
- TNGX $1.03
- 52 Week High
- MBI $7.46
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- MBI 51.98
- TNGX 74.27
- Support Level
- MBI $4.26
- TNGX $5.34
- Resistance Level
- MBI $4.52
- TNGX $5.63
- Average True Range (ATR)
- MBI 0.13
- TNGX 0.50
- MACD
- MBI 0.02
- TNGX -0.04
- Stochastic Oscillator
- MBI 74.39
- TNGX 84.15
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.